Radical Surgery Followed by Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen for the Treatment of Hepatocellular Carcinoma

NCT02632188 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Liver Cancer

Interventions

PROCEDURE: Postoperative routine treatment
BIOLOGICAL: DC-PMAT treatment

Sponsor

Second Military Medical University